Interestingly, we find that deep somatic deletions do frequently contribute to biallelic loss of BRCA2 or RAD51C, occurring in 10% of CHORD-HRD patients pan-cancer (Supplementary Data 5). This evidence concerns the gene BRCA2 and cancer.